BPC-157 DOSING & ADMINISTRATION BPC-157 is administered as a subcutaneous injection
Similar content being viewed by others Introduction Diabetes mellitus is a metabolic illness with a high level of blood glucose, and diabetes can cause numerous consequences, including heart disease, renal disease, retinopathy, and neuropathy 1,2
DOI: 10.1111/dom.70660
Core equipment: 1000L synthesis reactor, preparative HPLC (300mm column diameter), freeze dryer (15m shelf area), GC-MS/MS and multiple HPLC units, supporting production from gram to hundreds of kilograms
Insert the needle into the sterile water vial and inject the air into it
It is designed as a once-weekly injectable treatment for obesity, working via amylin receptors rather than the GLP-1 pathway used by most current weight loss medications